Ryunosuke Kogo

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Prognostic Difference According to the Site of Origin (Major vs. Minor) of Salivary Gland Carcinoma.

Prognostic Difference According to the Site of Origin (Major vs. Minor) of Salivary Gland Carcinoma.

Journal: Anticancer research
Published: February 04, 2026

Efficacy of Lenvatinib Therapy for Thyroid Cancer by Pathological Type: A Retrospective Real-world Study.

Efficacy of Lenvatinib Therapy for Thyroid Cancer by Pathological Type: A Retrospective Real-world Study.

Journal: In vivo (Athens, Greece)
Published: June 16, 2025

Rare Head and Neck Neuroendocrine Neoplasms: A Retrospective Study of Prognosis and Treatment Outcomes.

Rare Head and Neck Neuroendocrine Neoplasms: A Retrospective Study of Prognosis and Treatment Outcomes.

Journal: Cancer diagnosis & prognosis
Published: March 15, 2025

Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy.

Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy.

Journal: Anticancer research
Published: August 10, 2024

Temporoparietal Fascial Flap Combined With Vascularized Outer Table Calvarial Bone Graft and Entire Temporalis Muscle: A Stable Pedicled Flap for Orbital Floor Reconstruction After Total Maxillectomy.

Temporoparietal Fascial Flap Combined With Vascularized Outer Table Calvarial Bone Graft and Entire Temporalis Muscle: A Stable Pedicled Flap for Orbital Floor Reconstruction After Total Maxillectomy.

Journal: The Journal of craniofacial surgery
Published: July 11, 2024

Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation.

Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation.

Journal: Cancers
Published: June 20, 2024

Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma.

Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma.

Journal: Cancer diagnosis & prognosis
Published: June 03, 2024

BRAF mutation in five cases of sinonasal ameloblastic tumors and their clinical course: a case report.

BRAF mutation in five cases of sinonasal ameloblastic tumors and their clinical course: a case report.

Journal: Journal of medical case reports
Published: May 06, 2024

Clinical Analysis of Oral Squamous Cell Carcinoma: A Single-institution Experience.

Clinical Analysis of Oral Squamous Cell Carcinoma: A Single-institution Experience.

Journal: Cancer diagnosis & prognosis
Published: December 01, 2023

Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments.

Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: July 31, 2023

Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2.

Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2.

Journal: Scientific reports
Published: July 13, 2023

Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.

Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.

Journal: In vivo (Athens, Greece)
Published: May 08, 2023
Showing 1-12 of 39

Last Updated: 09/26/2026